Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Manuel Romero-Gómez

Catedrático

Universidad de Sevilla

Spain

Research Interests

Explore related searches

Professors in Spain

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (10)

Javier Ampuero

Instituto de Biomedicina de Sevilla

SPAIN

View details

William Alazawi

Professor

Queen Mary University of London

UNITED KINGDOM

View details

Alan Bonder

Associate Professor of Medicine. Medical Director of Liver Transplant

Beth Israel Deaconess Medical Center

UNITED STATES

View details

Salvatore Petta

University of Palermo

ITALY

View details

Jörn M. Schattenberg

Director

Saarland University Medical Center

GERMANY

View details

Stefan Zeuzem

Professor of Medicine

University Hospital

GERMANY

View details

Ricardo Gomez Huelgas

Titular Professor

University of Malaga

SPAIN

View details

Emmanuel Tsochatzis

Professor of Hepatology and Consultant Hepatologist

University College London

UNITED KINGDOM

View details

Christopher Rose

Full Professor

Université de Montréal

CANADA

View details

Cyrielle Caussy

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Manuel Romero-Gómez

Research Interests

Explore related searches

Articles (20)

Screening for Metabolic Dysfunction-Associated Steatohepatitis in Adults with Type 2 Diabetes in the U.S. and 5 European Countries: A Cost-Utility Analysis

Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice

A randomized trial of viral vector and adjuvanted protein HBV therapeutic vaccine in people with chronic hepatitis B on nucleos(t)ide analogs

Care Pathways for Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): A State‐of‐The‐Art Review

Phenotype-Specific Mitochondrial Responses to Mediterranean Diet and Exercise in Elderly Obesity

Letter to the Editor: Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content

A European Survey to Identify Challenges in the Management of Metabolic Dysfunction‐Associated Steatotic Liver Disease

A social media listening study of patients' experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD study

Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease on Fatigue and Pruritus in Primary Sclerosing Cholangitis: A U.S. Single-Center Study

Resmetirom in the Management of MASLD: What Clinicians Need to Know

Advancing precision medicine in metabolic dysfunction-associated steatotic liver disease

Metabolic Dysfunction-Associated Steatotic Liver Disease Alters Brain Function and Behavior: Insights from Liver-Targeted siRNA Therapy

Controversias en la nomenclatura: de la esteatohepatitis no alcohólica al espectro completo de la esteatosis hepática

Review Article: GLP‐1 Receptor Agonists and Glucagon/GIP/GLP‐1 Receptor Dual or Triple Agonists—Mechanism of Action and Emerging Therapeutic Landscape in MASLD

Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD

Ammonia-induced stress response in liver disease progression and hepatic encephalopathy

Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach

Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome

Looking for the best algorithm in the diabetes population for advanced fibrosis detection: The best is the enemy of the good

Risk of liver-related events in metabolic dysfunction–associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria

Collaborators (10)

Javier Ampuero

William Alazawi

Alan Bonder

Salvatore Petta

Jörn M. Schattenberg

Stefan Zeuzem

Ricardo Gomez Huelgas

Emmanuel Tsochatzis

Christopher Rose

Cyrielle Caussy

Make your next move.